Lebenthal Holdings’s Core Laboratories CLB Stock Holding History

Lebenthal Holdings’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$2.74M	Sell	22,123 -1,772	-7%	-$214K	0.34%	82
2016 Q1	$2.69M	Sell	23,895 -7,934	-25%	-$824K	0.47%	60
2015 Q4	$3.46M	Sell	31,829 -1,308	-4%	-$150K	0.81%	28
2015 Q3	$3.31M	Sell	33,137 -638	-2%	-$69.4K	0.76%	22
2015 Q2	$3.85M	Buy	33,775 +1,914	+6%	+$232K	0.79%	23
2015 Q1	$3.33M	Buy	+31,861	New	+$3.39M	0.78%	17

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

Lebenthal Holdings's CLB Position: Q2 2016 in Review

Lebenthal Holdings reduced its Core Laboratories (CLB) stake by 7.4% in Q2 2016, selling an estimated $214K and leaving 22,123 shares worth $2.74M. The position accounts for 0.34% of the portfolio, ranked #82.

Lebenthal Holdings first reported a position in CLB in Q1 2015 and has held it in 6 quarters since. The position peaked at $3.85M in Q2 2015. 383 funds tracked by Wall St. Rank hold CLB as of Q2 2016.

Lebenthal Holdings held 22,123 shares of Core Laboratories worth $2.74M as of Q2 2016.
Lebenthal Holdings sold 1,772 Core Laboratories shares in Q2 2016, an estimated $214K.
Core Laboratories made up 0.34% of Lebenthal Holdings's portfolio in Q2 2016, its #82 holding.
Lebenthal Holdings first reported a position in Core Laboratories in Q1 2015 and has held it in 6 quarters since.
Lebenthal Holdings's Core Laboratories position peaked at $3.85M in Q2 2015.
383 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2016.

Based on Lebenthal Holdings's 13F filing for Q2 2016, filed 19 Aug 2016.